oxidative stress, septic shock, and survival matthew greenwood april 29, 2015
TRANSCRIPT
Hypothesis: double blockade of complement C5 and the TLR coreceptor CD14 will improve survival during polymicrobial sepsis
Methods
• Use cecal ligation model to induce polymycrobial sepsis
• Treat C57BL/6 mice with anti-inflammatory agents– Coversin– Anti-mouse CD14
• Monitor – Levels of cytokines and other biomarkers– Mouse survival
What is Coversin?
• Inhibitor of complement C5– Prevents immune chemotaxis– Prevents formation of membrane attack system
• Originally from Ornithodoros moubata
http://www.vipimmunopharma.com/coversin/
http://lymeaware.free.fr/lyme/Websave/maladiesatiques/www.maladies-a-tiques.com/Ornithodoros%20moubata.jpg
Conclusions
• Combined C5 and CD14 inhibition significantly improves systemic inflammation, clinical signs, and survival rate
• Reducing the magnitude and duration of both the pro- and anti-inflammatory conditions improves outcome
Future directions
• Correlate cytokine levels with mortality and morbidity
• Treat with antibiotics with the immunosupressants
• Testing in humans to improve patient outcomes
• Hypothesis: protecting mitochondria with mitochondrial targeted antioxidants will alleviate myocardial inflammation and rescue heart function in sepsis
Methods
• Used intratracheal injection of Streptococcus pneumonia to induce sepsis
• Sprague-Dawley male rats served as the model organism
• Administered Mito-Vit-E in a 21.5 uMol/kg dose
Conclusions
• Mitochondrial targeted Vitamin E– Improved antioxidant capacity– Reduced Oxidation of mitochondrial molecules– Protected mitochondrial structure– Reduced Cytokine production– Reduced neutrophil infiltration– Protected heart function
Future Directions
• Survival studies• Administer with antibiotics• Testing in humans to improve patient
outcomes
My Experiment
Hypothesis: Administration of reactive oxygen species or pro-oxidative species will improve immune response and survival following sepsis
Specific Aim: Determine the reactive oxygen species or oxidants that are able to boost immune response in healthy and immunosuppressed mice to recover from sepsis.